JENIL SHETH ELEVATED TO HEAD OF MARKETING AT ABBOTT, STRENGTHENING STRATEGIC HEALTHCARE LEADERSHIP

Jenil Sheth has been appointed Head of Marketing at Abbott, bringing extensive pharmaceutical experience across multiple therapeutic areas. With a strong background in product and sales management, he is expected to enhance Abbott’s market strategies and drive growth through deep industry insight and leadership expertise.

Jenil Sheth has been promoted to Head of Marketing at Abbott, marking a significant step in his career and reinforcing the company’s focus on strategic, market-driven growth. With years of experience in the pharmaceutical sector, Sheth brings a comprehensive understanding of both product and sales management, positioning him as a key figure in shaping Abbott’s marketing direction.

Over the course of his professional journey, Sheth has built expertise across a wide range of therapeutic areas, including cardiology, dermatology, oncology, nutraceuticals and general medicines. This breadth of experience has enabled him to navigate complex healthcare markets while aligning product strategies with evolving consumer and industry demands. His ability to integrate scientific insight with commercial acumen has made him a well-rounded leader in the healthcare marketing space.

In his new role, Sheth is expected to drive Abbott’s marketing initiatives with a sharper focus on innovation, relevance and growth. His approach, rooted in understanding both patient needs and market dynamics, is likely to play a crucial role in strengthening the company’s positioning across key therapeutic segments. Industry observers note that such leadership is increasingly vital in a landscape where healthcare marketing must balance regulatory frameworks, technological advancement and patient-centric communication.

Prior to this appointment, Sheth held important roles at Glenmark Pharmaceuticals, Merck Healthcare and Bioplus Lifesciences. These experiences have contributed to a deep and nuanced understanding of diverse markets and therapeutic categories. His tenure across these organisations has been marked by a consistent emphasis on growth strategies driven by data, market insights and cross-functional collaboration.

At Abbott, Sheth steps into a role that demands both strategic foresight and operational excellence. The company’s expansive portfolio and global reputation provide a platform for impactful leadership, and his appointment signals a continued investment in strengthening its marketing capabilities. As the pharmaceutical industry evolves with increasing focus on personalised care and digital transformation, leaders like Sheth are expected to bridge the gap between innovation and accessibility.

His promotion reflects not only his individual accomplishments but also a broader trend of organisations prioritising leaders who can blend scientific knowledge with business strategy. With his proven track record and multidimensional expertise, Sheth is poised to contribute significantly to Abbott’s next phase of growth, shaping how its products connect with healthcare professionals and patients alike.